急性心肌梗死中Mzb1调节线粒体功能的作用与机制研究
批准号:
82100316
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
张璐
依托单位:
学科分类:
心肌损伤、修复、重构和再生
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
张璐
中文摘要
线粒体功能障碍在心肌梗死的发病机制中起着至关重要的作用。深入探究心肌梗死后线粒体功能紊乱的作用机制已成为研究重点。在前期工作中,我们首次发现边缘区B和B1细胞特异性蛋白(Mzb1)定位于心肌细胞线粒体,且在急性心梗时表达显著降低;过表达Mzb1可有效改善受损的心肌细胞;同时,Mzb1可部分恢复受损心肌细胞的线粒体功能;预实验结果发现:在心肌细胞中过表达Mzb1抑制Drp-l的表达,Drp-1是线粒体裂分中的关键蛋白,急性心梗时Drp-1异常升高导致线粒体过度分裂。由此,我们提出科学假说:心肌缺血可能下调Mzb1表达,导致Drp-1表达或功能上调引起粒体动力学及功能紊乱。本项目拟在此基础上,利用延时共聚焦成像、线粒体追踪等技术阐释Mzb1在调节急性心肌梗死后线粒体功能的作用,解析下游及靶点信号通路,揭示Mzb1调控Drp-1介导线粒体功能障碍的新途径,为治疗心肌梗死提供潜在药物靶点。
英文摘要
Mitochondrial dysfunction plays an important role in the pathogenesis of myocardial infarction. In-depth exploration of the mechanism of mitochondrial dysfunction after myocardial infarction has become the focus of research. In our previous work, we found for the first time that marginal zone B and B1 cell specific proteins (Mzb1) were located in the mitochondria of cardiomyocytes and significantly decreased in acute myocardial infarction. Overexpression of Mzb1 could effectively improve the damaged cardiomyocytes. Meanwhile, Mzb1 could partially restore the mitochondrial function of damaged cardiomyocytes. The results of pre-experiment showed that overexpression of Mzb1 inhibited the expression of Drp-l in cardiomyocytes, and Drp-1 was the key protein in mitochondrial cleavage. Abnormal increased of Drp-1 in acute myocardial infarction led to excessive mitochondria fission. Therefore, we propose a scientific hypothesis: myocardial ischemia may induce the downregulation of Mzb1, resulting in the up-regulation or activation of Drp-1, resulting in mitochondrial dynamics imbalance and dysfunction. On this basis, delayed confocal imaging and mitochondrial tracking techniques was performed to explain the mechanism of Mzb1 in regulating mitochondrial function after acute myocardial infarction, to analyze downstream and target signal pathways, and reveal a new way for Mzb1 to regulate Drp-1-mediated mitochondrial dysfunction, and to provide potential drug targets for the treatment of myocardial infarction.
目的:本研究探讨了Mzb1在葛根素保护急性心肌梗死(AMI)小鼠心脏损伤和功能障碍中的作用。 .方法:在建立AMI模型前,C57BL/6小鼠分别以50 mg/kg和100 mg/kg剂量的葛根素预处理14天。通过结扎左冠状动脉前降支诱导AMI模型,并在体外用H2O2处理AC16心肌细胞。采用超声心动图评估心脏功能。通过DHE染色、烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶测定和DCFH-DA氧化荧光染色检测体内和体外活性氧(ROS)的生成。利用生物信息学分析预测Mzb1的潜在上游转录因子。 .结果:葛根素剂量依赖性地减少了AMI小鼠的心肌梗死面积和损伤,并伴随心脏功能的改善。AMI小鼠表现出心肌氧化应激、内质网(ER)应激、细胞凋亡和线粒体生物合成功能障碍的增加,而葛根素预处理抑制了这些变化。葛根素还阻止了AMI小鼠心脏或H2O2处理的AC16细胞中Mzb1的下调。与体内研究结果一致,葛根素抑制了H2O2诱导的心肌细胞凋亡、内质网应激和线粒体功能障碍,而这些作用被siRNA Mzb1减弱。此外,JASPAR网站预测KLF4可能是Mzb1的转录因子。在心肌细胞损伤模型中,葛根素部分逆转了KLF4的表达,而KLF4抑制剂(kenpaullone)抑制了Mzb1的表达并影响其功能。 .结论:这些结果表明,葛根素通过上调KLF4/Mzb1通路减轻氧化应激和内质网应激,从而保护心脏损伤。葛根素可能为缺血性心脏病的预防和治疗提供新的策略。
国内基金
海外基金